FRISCO, Texas, Nov. 28, 2016 /PRNewswire/ -- True Health is supporting November's Lung Cancer Awareness Month by calling for a renewed effort for smoking cessation and greater awareness among high-risk patients for early lung cancer testing. More than 16 percent of U.S. adults are active smokers and more than 21 percent are ex-smokers. For high-risk patients, True Health's EarlyCDT-Lung blood test has the potential to signal the presence of cancer up to four years earlier than other methods of cancer detection. Logo - http://photos.prnewswire.com/prnh/20161128/443137LOGO Patients at high risk for lung cancer who take advantage of the True Health EarlyCDT-Lung test submit blood samples that are tested for elevated levels of seven autoantibodies validated against lung cancer. Elevated levels of any one of these antibodies above a predetermined cut-off suggests that a tumor might be present. "Lung cancer is one of the more treatable cancers, if caught early - a patient can have up to a 90 percent survival rate," said True Health Diagnostics CEO Chris Grottenthaler. "We urge doctors to work with patients to develop smoking cessation plans and make use of the EarlyCDT-Lung test to assess the risk that certain patients face in developing lung cancer. Healthcare professionals now may be able to detect the antibodies produced when tumor cells are present in the lungs, before the tumor itself is detectable." Almost 80 percent of lung cancer is diagnosed after it has spread to other organs. EarlyCDT-Lung detects lung cancer earlier, with an overall specificity of 93 percent and accuracy of 92 percent. Without the benefit of EarlyCDT-Lung test results, lung cancer may not be detected until later stages. "There are more than 480,000 smoking-related deaths in the U.S. every year. It is a major modifiable risk factor for both lung cancer and heart disease. True Health encourages patients to make use of smoking cessation techniques and, if necessary, to know their risk by asking a physician for an EarlyCDT-Lung test," said Grottenthaler.